Dr. Diane Reidy-Lagunes

Dr. Diane Reidy-Lagunes, MD is a highly regarded medical oncologist and academic leader currently serving as Chief of the Division of Medical Oncology at Duke Cancer Institute. She previously held key leadership roles at Memorial Sloan Kettering Cancer Center (MSKCC), where she served as the founding Director of the Center for Young Onset Cancer and a leading faculty member in gastrointestinal oncology. Dr. Reidy-Lagunes earned her medical degree from the University of Medicine and Dentistry of New Jersey, completed her residency in internal medicine at Mount Sinai Medical Center, and pursued fellowship training in medical oncology at MSKCC. Board-certified in both internal medicine and medical oncology, she brings clinical expertise and compassionate care to patients with gastrointestinal malignancies and rare neuroendocrine tumors.

A recognized expert in her field, Dr. Reidy-Lagunes has led pivotal clinical trials focused on improving outcomes for patients with colorectal, pancreatic, and neuroendocrine cancers. Her research emphasizes precision medicine, immunotherapy, and novel drug development, often targeting difficult-to-treat gastrointestinal tumors. She has authored numerous peer-reviewed publications and serves on advisory boards and national cooperative groups aimed at refining standards of care and expanding treatment access. At MSKCC, she helped establish specialized programs for early-onset colorectal cancer and led multidisciplinary tumor boards to integrate research and patient care in real time.

Beyond her clinical and research endeavors, Dr. Reidy-Lagunes is a passionate advocate for patient-centered care and public education. She is the host of MSK’s widely acclaimed “Cancer Straight Talk” podcast, where she translates complex medical topics into relatable guidance for patients and families. Her work has been recognized by multiple teaching awards and public health initiatives. Now at Duke, she continues to elevate standards in oncology through her dedication to mentorship, patient advocacy, and translational science. With her blend of academic excellence and humanistic leadership, Dr. Reidy-Lagunes stands at the forefront of innovation in gastrointestinal and neuroendocrine cancer care.